助手标题  
全文文献 工具书 数字 学术定义 翻译助手 学术趋势 更多
查询帮助
意见反馈
   graves 在 内分泌腺及全身性疾病 分类中 的翻译结果: 查询用时:0.159秒
图标索引 在分类学科中查询
所有学科
内分泌腺及全身性疾病
世界文学
更多类别查询

图标索引 历史查询
 

graves
相关语句
  格雷夫斯
    Expression and Signification of cNOS mRNA in Graves' Disease and Hashimoto's Thyroiditis
    cNOS mRNA在格雷夫斯病和桥本甲状腺炎的表达及意义
短句来源
    Comprehensive evaluation of ~(131)I and antithyroid drugs to treat the Graves disease with a thyroid enlargement below grade-Ⅱ
    ~(131)碘和抗甲状腺药物治疗甲状腺肿大Ⅱ度以下的格雷夫斯病的综合评价
短句来源
    Investigation of serum leptin levels in Graves disease
    格雷夫斯病血清瘦素水平研究
短句来源
    The association between the CTLA-4 gene polymorphism in chromosome 2q31-q33 and Graves disease
    染色体2q31-q33区CTLA-4基因多态性与格雷夫斯病关系的研究
短句来源
    Objective To study the clinical manifestation of the Graves' Disease (GD) patients with hyperthyroidism after increasing food iodine and treated with antithyroid drugs.
    目的 对来自缺碘病区、经治疗后症状、体征消失而使用维持量抗甲药物的格雷夫斯病 (Graves'Disease,GD)患者 ,摄碘量增加后的临床特点进行分析。
短句来源
更多       
  “graves”译为未确定词的双语例句
    The Expression of TSH-β and Its Receptor as Well as TRH Receptor Gene in GI Tract of Graves' Disease Patients with Hyperthyroidism Accompanied by Chronic Gastritis or Diarrhea
    伴有慢性胃炎或腹泻的Graves病甲亢患者胃肠道组织中TSH-β和其受体以及TRH受体的基因表达
短句来源
    Clinical Study on the Injury of 1α Hydroxylase in Renal Tubule of Hypokalemic Patients with Hyperthyroidism of Graves' Disease
    Graves病甲状腺功能亢进症低血钾倾向患者肾小管1α羟化酶损害的临床研究
短句来源
    Genome-wide Scan of Graves' Disease in Chinese Han Pedigrees and Epidemiological Study in Pedigrees
    中国汉族Graves病的全基因组扫描基因定位研究及家系流行病学调查
短句来源
    Study on the Blood Supply to Thyroid and Arterial Embolization for the Treatment of Graves' Disease
    Graves病甲状腺的血供分析及动脉栓塞治疗
短句来源
    Study on Differentially Expressed Genes in Graves Disease and Papillary Thyroid Carcinoma by cDNA Microarray
    应用基因芯片技术对Graves病、甲状腺乳头状癌相关基因表达的研究
短句来源
更多       
查询“graves”译词为用户自定义的双语例句

    我想查看译文中含有:的双语例句
例句
为了更好的帮助您理解掌握查询词或其译词在地道英语中的实际用法,我们为您准备了出自英文原文的大量英语例句,供您参考。
  graves
Concomitant Graves' disease and primary hyperparathyroidism: clinical implications and preoperative localization of parathyroid
      
Association of Graves' disease and Graves' ophthalmopathy with the polymorphisms in promoter and exon 1 of cytotoxic T lymphocyt
      
This case report deals with severe congestive heart failure, dilatation of the left ventricle, and tachyarrhythmia without preexisting heart disease in a patient with Graves disease.
      
Radiotherapy for Graves' Orbitopathy: Results of a National Survey
      
Graves' orbitopathy (GO) is a widely accepted indication for radiation therapy (RT).
      
更多          


Thyroid stimulating antibody(TSAb)was detected by radioreceptor assay of TSHin patients with Graves' disease.The ability of serum Ig to displace the labelled TSHfrom the receptors is referred to as“TSH displacement activity(TDA)”.In untreatedGraves' disease,TDA was above normal in 24(85.7%)of 28 cases,and in patientswith Graves' disease treated with anti-thyroid drugs for less than 3 months,TDA waspositive in 7 of 10 cases.Among Graves' disease patients with symptoms controlledby maintenance...

Thyroid stimulating antibody(TSAb)was detected by radioreceptor assay of TSHin patients with Graves' disease.The ability of serum Ig to displace the labelled TSHfrom the receptors is referred to as“TSH displacement activity(TDA)”.In untreatedGraves' disease,TDA was above normal in 24(85.7%)of 28 cases,and in patientswith Graves' disease treated with anti-thyroid drugs for less than 3 months,TDA waspositive in 7 of 10 cases.Among Graves' disease patients with symptoms controlledby maintenance dose of anti-thyroid drugs and those in remission without anti-thyroiddrug maintenance,TDA was positive in only 2 of 12 cases.Among 3 patients withrecurrence of hyperthyroidism,TDA was positive in 2 cases.All the 5 patients withsimple goiter had normal TDA.TDA levels correlated well with 4-hour thyroidal ~(131)Iuptake in 20 Graves' disease patients.Thus,TSAb appears to be a prerequisite ofhyperthyroidism manifestations of Graves' disease,and this method may be employedto detect immunological remission of Graves' disease.

本文报道用促甲状腺激素(TSH)放射受体分析法测定 Graves 病病人血清甲状腺刺激抗体抑制或置换~(125)I-TSH 与人甲状腺细胞膜受体结合的活力,以 TSH 置换活力(TDA)表示之.在53例 Graves 病中,未治疗的28例,TDA 高于正常者占85.7%;治疗不满3个月的10例,有7例TDA 阳性;治疗一年以上并服用维持量的7例和已停止治疗而临床缓解的5例中,仅2例 TDA 阳性;复发的3例,有2例 TDA 阳性,5例单纯性甲状腺肿和10名正常对照者,TDA 均正常。Gra-ves 病的 TDA 水平与4小时吸~(131)碘率值密切相关(r=0.91,P<0.01)。以上资料表明:本试验可望成为检测 Grayes 病及判断治疗效果和预后的一种可靠方法.

A double-antibody RIA for anti-microsomal antibody in serum has been established in our laboratory soon after the purified microsomal antigen being avaiable to us. The antigen protein was radio-labeled ( 125I-Nal) by chloramine T. The relevant quality control indices were briefly discussed. The binding rate of 100 normal subjects assayed were x 10.3 ± 2.4% (4.7 - 15.9%), 95% were in between 5.5% and 15.1%. And that of 167 serum from the patients of thyroid diseases were:37/39(97%) of auto-immune thy-roiditis>...

A double-antibody RIA for anti-microsomal antibody in serum has been established in our laboratory soon after the purified microsomal antigen being avaiable to us. The antigen protein was radio-labeled ( 125I-Nal) by chloramine T. The relevant quality control indices were briefly discussed. The binding rate of 100 normal subjects assayed were x 10.3 ± 2.4% (4.7 - 15.9%), 95% were in between 5.5% and 15.1%. And that of 167 serum from the patients of thyroid diseases were:37/39(97%) of auto-immune thy-roiditis> 15%, 34/67 (42.2%) of Grave s dis. > 15%, and all the 61 non-autoimmune goiter were<15%. There is a good correlation, when concurrently tested with hemagg-lutiation method in 298 cases of various thyroid patients. After analysed the above data the author considered that the binding rate 15% is the suitable criterial value for normals and abnormals of our method.

本文报道甲状腺微粒体抗体放射免疫(双抗体法)测定。并对技术指标作了简要探讨。应用本法测定100例正常人,x为10.3±2.4%(4.7~15.9%)。共检测167例各种甲状腺病患者。39例自身免疫性甲状腺炎中95%>15%,67例 Grave's 中50.7%>15%,61例非自身免疫性甲状腺肿均<15%。本法与血凝法同时测定298例各种甲状腺病患者血清标本,二者的结果呈良好的相关性。根据实验结果并结合临床和病理,制定15%为甲状腺微粒体抗体放射免疫(双抗体法)测定正常和异常的临界值。

Two-hundred-eighty-four patients with Graves' disease were followed up retrospectively and prospectively for from 6 months to 25 years after cessation of antithyroid drugs. The remission rate was found to be 65.6% (149/227) at 2 years, 53.5% (68/127) at 5 years and 38.8% (19/49) at 10 years and over. In order to study the remission rate with respect to the duration of treatment, the patients were divided into 3 groups: short-term (6.7±1.5 mos), mid-term(14.3 ±2.3mos)and long-term(26.1 ± 8.3mos). The remission...

Two-hundred-eighty-four patients with Graves' disease were followed up retrospectively and prospectively for from 6 months to 25 years after cessation of antithyroid drugs. The remission rate was found to be 65.6% (149/227) at 2 years, 53.5% (68/127) at 5 years and 38.8% (19/49) at 10 years and over. In order to study the remission rate with respect to the duration of treatment, the patients were divided into 3 groups: short-term (6.7±1.5 mos), mid-term(14.3 ±2.3mos)and long-term(26.1 ± 8.3mos). The remission rate was not statistically different among the 3 groups. T3 suppression and TRH stimulation tests were performed on 62 cases at discontinuation of the drugs and repeated on 20 cases 1 year later. Response to T3 suppression varied significantly among different groups immediately following cessation of therapy, but no similar difference Was demonstrated 1 year later. The present study indicates that serum levels of T3 and T4 and size of the goiter before treatment and the results of T3 suppression test as well may be of some value in predicting the outcome of anti-thyroid drug therapy. Since most of the patients with long-term remission were those who had received short-term therapy, it is suggested that about 6-month drug administration would seem to be just as effective as therapy of I onger durations.

本文以回顾及前瞻性的方法对284例Graves病患者,经抗甲状腺药物治疗停药后,进行1/2~25年的随访观察。停药后2年的缓解率为65.6%(149/227),5年为53.5%(68/127),>10年为38.8%(19/49)。短程、中程及长程三种疗程组(分别治疗6.7±1.5月、14.3±2.3月及26.1±8.3月)的缓解率在统计学上无显著差异。62例于停药时进行T_3抑制试验及TRH兴奋试验,其中20例于停药1年时再复查此两项检查。停药时三组间T_3抑制试验结果有显著差异,但停药1年时则无明显差异。此外,本组结果提示,治疗前甲状腺肿的大小、血清T_3及T_4浓度,以及停药时的T_3抑制试验结果,在判断疗效上有一定的临床价值。

 
<< 更多相关文摘    
图标索引 相关查询

 


 
CNKI小工具
在英文学术搜索中查有关graves的内容
在知识搜索中查有关graves的内容
在数字搜索中查有关graves的内容
在概念知识元中查有关graves的内容
在学术趋势中查有关graves的内容
 
 

CNKI主页设CNKI翻译助手为主页 | 收藏CNKI翻译助手 | 广告服务 | 英文学术搜索
版权图标  2008 CNKI-中国知网
京ICP证040431号 互联网出版许可证 新出网证(京)字008号
北京市公安局海淀分局 备案号:110 1081725
版权图标 2008中国知网(cnki) 中国学术期刊(光盘版)电子杂志社